Katharina Kerner

Dr. Katharina Kerner


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2023 in Animals
Verified
Journal Article
Open access
PDF file
ISIngo Schäfer
Ingo Schäfer
APAxel Peukert
Axel Peukert
KKKatharina Kerner
Katharina Kerner
EMElisabeth Müller
Elisabeth Müller
Bacterial, protozoal, and viral vector-borne pathogens (VBPs) can cause infections in cats. There is little information on feline VBP prevalence in Germany. Stray cats are frequently exposed to vectors but receive no veterinary care. The aim of this study was to determine the prevalence of selected VBPs in stray cats. EDTA blood and serum samples were taken from apparently healthy stray cats during a spay/neuter campaign in the federal state of Thuringia. Overall, 11/50 (22%) and 32/50 (64%) cats tested positive for at least one VBP by direct and indirect detection methods, respectively. PCR testing of EDTA blood detected hemotropic Mycoplasma spp. in 12% of cats, Hepatozoon spp. in 10%, and Anaplasma phagocytophilum in 4%. PCR testing for Rickettsia spp. and piroplasms was negative. IFAT on serum samples showed 46% of cats had detectable antibodies for Bartonella spp., 30% for Rickettsia spp., and 16% for A. phagocytophilum. The cats were additionally tested for feline coronavirus, FIV, and FeLV to identify potential risk factors for pathogen contact and/or infections. No correlation between FIV and FeLV status and VBP positivity was detected. Anaplasma phagocytophilum, Rickettsia spp., and Bartonella spp. have zoonotic potential, and surveillance is recommended in the context of the One Health approach.

12 July 2025 in Animals
Verified
Journal Article
Open access
PDF file
Betina Boneva-Marutsova, PhDBetina Boneva-Marutsova, PhD
Betina Boneva-Marutsova, PhD
PMPlamen Marutsov
Plamen Marutsov
KKKatharina Kerner
Katharina Kerner
GGGeorgi Zhelev Georgiev
Georgi Zhelev Georgiev
This case report describes the following scenario: A 56-day-old Arabian filly presented with classical symptoms of respiratory distress and a rapidly deteriorating condition, despite intensive antimicrobial treatment, resulting in death. The post-mortem examination revealed severe bronchopneumonia with characteristic disseminated pus-containing nodules. Microbiological tests and PCR confirmed the presence of R. equi carrying the virulence-associated protein A (VapA) gene. The isolate was sensitive to macrolides and fluoroquinolones but showed resistance or intermediate susceptibility to several commonly used antimicrobials. This case highlights the diagnostic and therapeutic challenges posed by this intracellular pathogen and emphasizes the importance of early detection, targeted therapy, and biosecurity measures—especially in the absence of an effective commercial vaccine.

19 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Betina Boneva-Marutsova, PhDBetina Boneva-Marutsova, PhD
Betina Boneva-Marutsova, PhD
PMPlamen Marutsov
Plamen Marutsov
KKKatharina Kerner
Katharina Kerner
GZGeorgi Zhelev
Georgi Zhelev
The case describes the following scenario: A 56-day-old Arabian filly presented with classical symptoms of respiratory distress and a rapidly deteriorating condition despite intensive antimicrobial treatment, resulting in death. Post-mortem examination revealed severe bronchopneumonia with characteristic disseminated pus-containing nodules. Microbiological tests and PCR confirmed the presence of R. hoagii carrying the virulence-associated protein A (vapA) gene. The isolate was sensitive to macrolides and fluoroquinolones but showed resistance or intermediate susceptibility to several commonly used antimicrobials. This case highlights the diagnostic and therapeutic challenges posed by this intracellular pathogen and emphasizes the importance of early detection, targeted therapy, and biosecurity measures — especially in the absence of an effective commercial vaccine.